A healthcare company trying to launch a new headache curing drug. Should or shouldn't they invest when they already have a general painkiller in the market
Schedule mock interviews on the Meeting Board, join the latest community discussions in our Consulting Q&A and find like-minded Interview Partners to connect and practice with!
Back to overview
18
How would I approach this? Possible Framework?
2
4.2k

Be the first to answer!
Nobody has responded to this question yet.
Top answer

Vlad
edited on Jun 05, 2018
Coach
McKinsey / Accenture Alum / Got all BIG3 offers / Harvard Business School
Hi,
Hi,
I recommend starting with clarifying the objective - Which metrics you need to achieve with the product? Most probably it will be ROI.
I would also clarify whether it's our painkiller on the market or the product of the competitors since competition and cannibalization are the two different cases. Then I will follow up with the structure:
Analyze our product:
- The value proposition of a product compared to the painkiller
- Different use cases of a product compared to the painkiller
- Unit economics (Current unit costs and costs in relation to scale, Investments, ROI targets, Competitor / substitutes pricing)
- Key capabilities to compete (Patent, distribution, etc)
Analyze the market:
- Size and growth rates of the painkiller market
- Size and growth rate of headache drugs
- Regulation - are they both OTC? Prescribed? Is it different by geography?
Analyze the competitors:
- Market shares, growth rates, profits
- Product (Value proposition)
- Unit economics (Value proposition vs. price vs. costs)
- Key capabilities (Distribution, supply, assets, knowledge, etc)
investment decision:
- Costs, benefits, and investments
- ROI
- Risks
Best!
0 comments

Sidi
on Jun 05, 2018
Coach
McKinsey Senior EM & BCG Consultant | Interviewer at McK & BCG for 7 years | Coached 500+ candidates secure MBB offers
Hi Anonymous,
the new drug should be launched if the net value associated with this move exceeds the investment cost over the client's target investment horizon. Morover, Risk needs to be manageable.
So you have 4 buckets to investigate:
- Net value (expected profits of new drug + impact on profits of current painkiller (potential cannibalization!))
- Investment Horizon
- Investment need for launch of the new drug
- Wider risks associated with the new drug (regulation? competitive responses? consumer sentiment?...)
Cheers, Sidi
Similar Questions
Most Popular Posts
Applying to another role at BCG after receiving rejection
12
on Oct 10, 2025
Asia
7
100+

Top answer by
Hagen
Coach
Globally top-ranked MBB coach | >95% success rate | 9+ years consulting, interviewing and coaching experience
7 Answers
100+ Views


+4
Leadership examples PEI question MCK
12
on Oct 10, 2025
Europe
7
100+

Top answer by
Pedro
Coach
Most Senior Coach @ Preplounge: Bain | EY-Parthenon | RB | Principal level interviewer | PEI Expert | 30% in October
7 Answers
100+ Views

K
+4
Teneo Consulting TestGorilla Math Assessment Prep
19
on Oct 11, 2025
USA
3
400+

Top answer by
Jenny
Coach
Buy 1 get 1 free for 1st time clients | Ex-McKinsey Manager & Interviewer | +7 yrs Coaching | Go from good to great
3 Answers
400+ Views


Trouble with brainstorming
11
on Oct 12, 2025
USA
8
100+

Top answer by
Sidi
Coach
McKinsey Senior EM & BCG Consultant | Interviewer at McK & BCG for 7 years | Coached 500+ candidates secure MBB offers
8 Answers
100+ Views


+5
Final question to ask to the interviewer, MCK
12
on Oct 12, 2025
Europe
6
100+

Top answer by
Seongyun
Coach
Current OW Interviewer | Offers from McKinsey, OW, All Big 4 Strategy Houses | CV & Cover Letter Review
6 Answers
100+ Views


+3